Vice President, Head of Search & Evaluation

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the Head of Corporate Development, The VP, Head of Search & Evaluation is a senior leader within the Corporate Development organization responsible for setting the strategy for, building the organization around, and leading the identification, assessment, and advancement of external innovation opportunities that support Revolution Medicines' portfolio strategy and long-term growth objectives. Working in close partnership with leaders across Research, Development, Commercial, Corporate Strategy, Portfolio Management, and Executive Management, this individual will lead the company's search and evaluation activities across discovery- and clinical-stage opportunities. The role is accountable for developing and maintaining a robust pipeline of external opportunities, driving rigorous opportunity assessments, shaping strategic recommendations that inform portfolio and partnering decisions, and building a high-performing Search & Evaluation team with the capabilities and leadership depth to support the company's growth. The successful candidate will combine deep scientific and business acumen with exceptional organizational leadership, strategic judgment, and executive communication skills. This individual will serve as a key connector across the organization and a senior external-facing leader, ensuring that external innovation efforts are aligned with corporate strategy, therapeutic area priorities, and emerging opportunities in precision oncology and related fields. They will create an environment in which talented team members can exercise judgment, grow as leaders, and independently drive high-quality search and evaluation work at scale. Responsibilities External Innovation Strategy and Opportunity Identification Set the strategic direction for the company's search and evaluation of external innovation in partnership with senior cross-functional and executive stakeholders. Develop and execute search strategies that align with Revolution Medicines' research, development, and commercial priorities. Oversee the full portfolio of discovery- and clinical-stage search and evaluation activities, setting priorities and deploying team resources to maintain a robust pipeline of external opportunities aligned with portfolio priorities. Build an external sourcing engine and lead proactive opportunity identification through engagement with biotechnology companies, academic institutions, investors, entrepreneurs, and other innovation ecosystems, while enabling team members to develop and own high-value external relationships. Partner with Portfolio Management, Disease Strategy, Research, and Development leaders to identify areas where external innovation can create strategic value and enhance portfolio competitiveness. Maintain a comprehensive understanding of relevant scientific, clinical, and competitive landscapes to identify emerging opportunities and trends. Opportunity Assessment and Diligence Leadership Provide leadership and oversight for cross-functional diligence and opportunity assessments, ensuring teams integrate scientific, clinical, commercial, strategic, operational, and financial perspectives into clear executive recommendations. Establish and continuously raise the bar for evaluation frameworks, decision criteria, and diligence standards that enable the team to deliver consistent, rigorous, and efficient assessments. Mobilize and guide cross-functional diligence teams across Research, Clinical Development, Regulatory, Commercial, Finance, Intellectual Property, Legal, and other functions, while empowering Search & Evaluation leaders to independently drive individual opportunities. Ensure key risks, opportunities, and strategic considerations are thoroughly evaluated and clearly communicated to decision-makers. Develop balanced recommendations regarding prioritization, resource allocation, and partnership strategy. Portfolio and Governance Leadership Establish and maintain scalable frameworks, operating rhythms, and governance for opportunity evaluation, diligence, prioritization, resource allocation, and decision-making. Provide portfolio-level oversight of opportunities moving through evaluation and governanc #J-18808-Ljbffr revolutionmedicines